Cytochrome P450 3A proteins are expressed in B lymphocytes but not in T lymphocytes

Pharmacogenetics

Volumn 9, Issue 2, 1999, Pages 263-265

  Sempoux, Christine ^a   Stärkel, Peter ^a   Stevens, Martine ^a   Den Berge, Véronique Van ^a   Horsmans, Yves ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

B and T lymphocytes; Cytochrome P450 3A; Immunoblotting; Immunohistochemistry

Indexed keywords

CYTOCHROME P450;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MALE; NEUTROPHIL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; WESTERN BLOTTING;

ADULT; ARYL HYDROCARBON HYDROXYLASES; B-LYMPHOCYTES; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; IMMUNOHISTOCHEMISTRY; OXIDOREDUCTASES, N-DEMETHYLATING; T-LYMPHOCYTES;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0032784628     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Beaune PH, Kremers P, Letawe-Grougon F, Gielen JE. Monoclonal antibodies against human liver cytochrome P-450. Biochem Pharmacol 1985; 34:3547-3552.
2. Berg PA, Becker EF. The lymphocyte transformation test - a debated method for the evaluation of drug allergic hepatic injury. J Hepatol 1995; 22:115-118.
3. Guengerich FP. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 1991; 4:391-407.
4. Janardan SK, Lown KL, Schmiedlin-Ren P, Thummel KE, Watkins PB. Selective expression of CYP3A5 and not CYP3A4 in human blood. Pharmacogenetics 1996; 6:379-385.
5. Murray GI, Barnes TS, Sewell HF, Ewen SW, Melvin WT, Burke MD. The immunocytochemical localization and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450. Br J Clin Pharmacol 1988; 25:465-475.
6. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6:1-42.
7. Ribrag V, Massaad L, Janot F, Morizet J, Grouyette A, Chalot GG. Main drug-metabolizing enzyme systems in human non-Hodgkin's lymphomas sensitive or resistant to chemotherapy. Leuk Lymphoma 1995; 18:303-310.
8. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994; 270:414-423.
9. Spielberg SP. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. Fed Proc 1984; 43:2308-2313.
10. Stärkel P, Sempoux C, Van Den Berge V, Stevens M, De Saeger C, Horsmans Y. CYP3A protein is present in human lymphocytes but its expression is not induced by rifampicin [abstract]. ISSX Proceedings 1997; 12:51.